This action was commenced on December 24, 2007, with its most recent Amended Statement of Claim being filed on February 26, 2010. It was brought as a proposed class proceeding on behalf of the plaintiff and all other persons resident in British Columbia who purchased Children’s Cough Medicine for use by children under the age of six, that was supplied, offered for sale, advertised or promoted by the Defendants between December 24, 1997 and December 21, 2011.
In December, 2011, the action was certified as a class proceeding by the British Columbia Supreme Court. In January, 2014, the British Columbia Court of Appeal overturned that decision and declined to certify the action as a class proceeding. Leave to the Supreme Court of Canada was denied. The action has now been discontinued without costs.
Settlements totaling $290,000 were reached with Trillium Health Care Products Inc., Vita Health Products Inc. and Procter & Gamble Inc. The settlement funds were used to pay out disbursements that were incurred in litigating the actuin, and all remaining funds ($154,788.89) will be distributed by a cy-pres payment to the BC Children’s Hospital Foundation.
Please attach the following documents:
Children’s Cough Medicine - View